Matches in SemOpenAlex for { <https://semopenalex.org/work/W2410097449> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2410097449 endingPage "40" @default.
- W2410097449 startingPage "32" @default.
- W2410097449 abstract "Transportations of rivastigmine containing liposomes across Caco-2 cells were studied and in vitro test results were compared with in vivo results. MTT test was used for cell viability studies. Series of formulations were prepared containing rivastigmine which is used for the treatment of Alzheimer's disease. Characterization and stability studies for liposome formulations were performed. Encapsulation efficiencies of liposomes were 35.4%, 25.2% and 29.9% for rivastigmine, rivastigmine-sodium taurocholate, rivastigmine-dimethyl-beta-CD liposomes, respectively. In stability studies, particle size and size distribution, zeta potential, rivastigmine amounts were determined and shelf lives of liposomes were calculated. Penetration properties of rivastigmine through Caco-2 cells, dialysis membrane and kinetics of release from liposomes were determined. Permeability coefficients were calculated after diffusion studies. The highest value of % cumulative amount of rivastigmine passed through caco-2 cell cultures was found to be 87.2% for rivastigmine-sodium taurocholate solution and 12.8% for rivastigmine-sodium taurocholate liposome. The highest permeability coefficient value was obtained with sodium taurocholate liposomes for -0.75. Rivastigmine liposomes and solutions were also applied to animals. Acetyl choline esterase (AChE) activity was determined by the Ellman method on mice. %AChE inhibition values were calculated using blood and brain tissue samples. The physical appearances of the brains were investigated by TEM microscope. The highest value of AChE inhibition was observed for rivastigmine and sodium taurocholate liposomes. The histological investigations and observations also supported these results." @default.
- W2410097449 created "2016-06-24" @default.
- W2410097449 creator A5061354081 @default.
- W2410097449 creator A5070982337 @default.
- W2410097449 creator A5072243576 @default.
- W2410097449 creator A5084584448 @default.
- W2410097449 creator A5086620868 @default.
- W2410097449 date "2010-01-01" @default.
- W2410097449 modified "2023-10-11" @default.
- W2410097449 title "Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2)." @default.
- W2410097449 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20187576" @default.
- W2410097449 hasPublicationYear "2010" @default.
- W2410097449 type Work @default.
- W2410097449 sameAs 2410097449 @default.
- W2410097449 citedByCount "8" @default.
- W2410097449 countsByYear W24100974492013 @default.
- W2410097449 countsByYear W24100974492015 @default.
- W2410097449 countsByYear W24100974492016 @default.
- W2410097449 countsByYear W24100974492018 @default.
- W2410097449 countsByYear W24100974492019 @default.
- W2410097449 crossrefType "journal-article" @default.
- W2410097449 hasAuthorship W2410097449A5061354081 @default.
- W2410097449 hasAuthorship W2410097449A5070982337 @default.
- W2410097449 hasAuthorship W2410097449A5072243576 @default.
- W2410097449 hasAuthorship W2410097449A5084584448 @default.
- W2410097449 hasAuthorship W2410097449A5086620868 @default.
- W2410097449 hasConcept C142724271 @default.
- W2410097449 hasConcept C185154212 @default.
- W2410097449 hasConcept C185592680 @default.
- W2410097449 hasConcept C2776332859 @default.
- W2410097449 hasConcept C2779134260 @default.
- W2410097449 hasConcept C2779483572 @default.
- W2410097449 hasConcept C2780904820 @default.
- W2410097449 hasConcept C43617362 @default.
- W2410097449 hasConcept C55493867 @default.
- W2410097449 hasConcept C71924100 @default.
- W2410097449 hasConcept C98274493 @default.
- W2410097449 hasConceptScore W2410097449C142724271 @default.
- W2410097449 hasConceptScore W2410097449C185154212 @default.
- W2410097449 hasConceptScore W2410097449C185592680 @default.
- W2410097449 hasConceptScore W2410097449C2776332859 @default.
- W2410097449 hasConceptScore W2410097449C2779134260 @default.
- W2410097449 hasConceptScore W2410097449C2779483572 @default.
- W2410097449 hasConceptScore W2410097449C2780904820 @default.
- W2410097449 hasConceptScore W2410097449C43617362 @default.
- W2410097449 hasConceptScore W2410097449C55493867 @default.
- W2410097449 hasConceptScore W2410097449C71924100 @default.
- W2410097449 hasConceptScore W2410097449C98274493 @default.
- W2410097449 hasIssue "1" @default.
- W2410097449 hasLocation W24100974491 @default.
- W2410097449 hasOpenAccess W2410097449 @default.
- W2410097449 hasPrimaryLocation W24100974491 @default.
- W2410097449 hasRelatedWork W122210468 @default.
- W2410097449 hasRelatedWork W1543009675 @default.
- W2410097449 hasRelatedWork W2014150467 @default.
- W2410097449 hasRelatedWork W2031806580 @default.
- W2410097449 hasRelatedWork W2047233271 @default.
- W2410097449 hasRelatedWork W2054546290 @default.
- W2410097449 hasRelatedWork W2077134890 @default.
- W2410097449 hasRelatedWork W2117695443 @default.
- W2410097449 hasRelatedWork W2321587902 @default.
- W2410097449 hasRelatedWork W2327012218 @default.
- W2410097449 hasRelatedWork W2336547107 @default.
- W2410097449 hasRelatedWork W2355334086 @default.
- W2410097449 hasRelatedWork W2383493524 @default.
- W2410097449 hasRelatedWork W2384373960 @default.
- W2410097449 hasRelatedWork W2390365343 @default.
- W2410097449 hasRelatedWork W2606003614 @default.
- W2410097449 hasRelatedWork W2608437700 @default.
- W2410097449 hasRelatedWork W2802961958 @default.
- W2410097449 hasRelatedWork W3028198919 @default.
- W2410097449 hasRelatedWork W791162554 @default.
- W2410097449 hasVolume "65" @default.
- W2410097449 isParatext "false" @default.
- W2410097449 isRetracted "false" @default.
- W2410097449 magId "2410097449" @default.
- W2410097449 workType "article" @default.